Clinical Trials Logo

Preterm Infant clinical trials

View clinical trials related to Preterm Infant.

Filter by:

NCT ID: NCT04608279 Completed - Renal Failure Clinical Trials

Urinary Creatinin/Protein Ratio in Preterms

PROTI-PREMA
Start date: January 2017
Phase:
Study type: Observational

From the first days of life, the newborn presents a "physiological" proteinuria explained by the coexistence of a glomerular and tubular immaturity, all the more marked as the gestational age (GA) is weak. In the child term, proteinuria decreases the first month and its persistence is the marker of kidney damage. The persistence of proteinuria in preterm infants is also considered a marker of renal impairment; however, neither the "physiological" values nor the pattern of urinary excretion of proteins in the first month of life are known. The proteinuria / creatininuria ratio is a validated indicator of proteinuria, as it is correlated with 24-hour urine proteinuria.

NCT ID: NCT04382976 Completed - Preterm Infant Clinical Trials

The Incidence and the Risk Factors of Nephrocalcinosis in Very Preterm Infants

Start date: October 1, 2018
Phase:
Study type: Observational

The study aims to assess the incidence and the risk factors of nephrocalcinosis in very preterm infants using patient data collected during hospitalisation at the Neonatology Centre.

NCT ID: NCT04348799 Completed - Clinical trials for Bronchopulmonary Dysplasia

Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia

BPD
Start date: January 1, 2019
Phase:
Study type: Observational

To investigate the relationship between bronchopulmonary dysplasia and thrombocytopenia.

NCT ID: NCT04304807 Completed - Clinical trials for Necrotizing Enterocolitis

Effect of Melatonin on Feeding Intolerance and Incidence of Necrotizing Enterocolitis in Preterm Infants

Start date: December 24, 2018
Phase: Phase 4
Study type: Interventional

Assesses the efficacy of melatonin in treatment of feeding intolerance in preterm infants, the time needed to reach full enteral intake, the incidence of necrotizing enterocolitis and measures the level of tumor necrosis factor-alpha as a marker of oxidative stress.

NCT ID: NCT04283799 Completed - Preterm Infant Clinical Trials

Using a New Human Milk Fortifier to Optimize Feeding

Start date: March 16, 2020
Phase: N/A
Study type: Interventional

This study aims to compare the safety and efficacy of a new HMF and those of other HMF used before in very preterm infants.

NCT ID: NCT04277923 Not yet recruiting - Preterm Infant Clinical Trials

Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature Infants

Start date: February 2020
Phase: Phase 4
Study type: Interventional

Abnormal liver function or cholestasis is the result of multiple factors, include low birth weight, smaller than gestational age, preterm birth, infection, lipid emulsion (LE) in parenteral nutrition (PN), insufficient enteral nutrition (EN) etc. Most are inevitable, but the LEs in PN can be selected. So the investigators compare two LEs, and want to see if the SMOF LE can improve hepatic index in preterm infants.

NCT ID: NCT04266717 Completed - Preterm Infant Clinical Trials

A Novel Parent Education Program for Early Intervention

Start date: January 17, 2018
Phase: N/A
Study type: Interventional

One in ten infants born in the USA is born preterm before 37 weeks of gestation and 50% of those will have motor and cognitive delays requiring intervention at school age. Because existing assessments do not reliably identify motor and cognitive delays early in development, many infants born preterm do not receive early intervention until they are older and their delays are more pronounced. This project aims to address the need for an effective, affordable, novel early intervention model for the first months of life for preterm infants.

NCT ID: NCT04241263 Recruiting - Preterm Infant Clinical Trials

Neonatal Wireless Monitoring System for Intensive Care

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Babies who require intensive care need to have their heart rate, oxygen levels and temperature measured continuously using specially designed monitors. These monitors allow the clinical team to constantly assess the baby and see if they are becoming unwell. However, these monitors each have separate wires to connect them to the baby. Another important part of care in these babies is being able to allow parents to hold their babies, getting them out of their incubators to be cuddled. This is called Kangaroo care and has been shown to impact on long term health for both babies and parents. We have designed a system to free babies of the wires that tether them to the monitors. This system has been tested in adults and we now want to test them on the babies. There are two study parts with two different questions: 1. How good is the data? This will compare the new wireless system with the existing system. Babies will have both standard wired monitors and the new wireless monitor on at the same time so we can compare the data to see how good is the quality of the data collected on the new system. 2. What do parents and staff think about the wireless system during Kangaroo care? Babies who no longer need monitoring (but who previously had been monitored with the wired system), will have the wireless system attached and the parent will take their baby from the cot for Kangaroo Care. After the baby has been placed back in the cot, we will conduct interviews with the parent and the nurse to find out what they thought of the new system. We hope this will help the investigators to understand about how good the data is we collect and how we might be able to improve the system.

NCT ID: NCT04089540 Completed - Preterm Infant Clinical Trials

New Intubation Method to Achieve Circulatory Stability and to Reduce Number of Intubation Attempts in Neonates

NOONA
Start date: October 2016
Phase: N/A
Study type: Interventional

This is a randomized controlled pilot study investigating a new intubation method in newborn infants. In contrast to the conventional intubation method, in the new method the respirator is connected to the tube prior to insertion into the mouth (oral intubation) or into the nose (nasopharyngeal intubation). As a result, an oxygen flow is already administered via the tube during the intubation process. Heart rate, arterial oxygen saturation (SpO2) and cerebral tissue oxygenation (using near-infrared spectroscopy) are recorded in both the study and control groups during intubation. Hypothesis - The new intubation method is safe - The new intubation method leads to a reduction in the number of intubation attempts - The new intubation method leads to a reduction of desaturations and bradycardia during intubation - In the long term, it could lead to a reduction in morbidity and mortality

NCT ID: NCT04062851 Completed - Preterm Infant Clinical Trials

Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants

Start date: May 3, 2019
Phase: N/A
Study type: Interventional

The practice of checking gastric residuals is not evidence based. The amount of gastric residual volume (GRV) does not correlate with either feeding intolerance or development of NEC. We hypothesize that not monitoring GRV in infants with birth weights < 1,250 g, and who are being fed intermittently by gastric tube, will result in earlier attainment of full feeding. This is an unblinded randomized controlled trial where GRV will not be checked routinely in the intervention group.